http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
식물세포배양에 의한 항암제 Paclitaxel의 대량 생산
최형균,손주선,나광휘,홍승서,박연성,송재영,Choi, Hyung-Kyoon,Son, Joo-Sun,Na, Gwang-Hwee,Hong, Seung-Suh,Park, Yeon-Seung,Song, Jai-Young 한국식물생명공학회 2002 식물생명공학회지 Vol.29 No.1
Samyang Genex succeeded in commercialization of anticancer agent-paclitaxel by plant cell culture technology. The core technology of Samyang Genex relating paclitaxel production includes cell line development, cell line preservation, cell culture, scale-up technology, and purification technology. On the basis of the research, Samyang Genex built the factory operated by CGMP (current good manufacturing practice). The paclitaxel-Genexol$^{TM}$-is commercially available in Korea, and it will be launched to world market including USA after approval of US FDA.